The last NephJC of the year brought us a cool discussion on if cooling dialysate could help mitigate the effects of intradialytic hypotension. Get caught up with the chat in the latest edition of #TenTweetNephJC.
This week, we will discuss the ongoing saga of blood pressure targets in patients with hypertension. This time its ESPRIT (Effects of Intensive Systolic Blood Pressure Lowering Treatment in Reducing Risk of Vascular Events) making a case for case for intensive BP control in most hypertensive individuals, including those with a history of diabetes and stroke.
The last NephJC of the year brought us a cool discussion on if cooling dialysate could help mitigate the effects of intradialytic hypotension. Get caught up with the chat in the latest edition of #TenTweetNephJC.
Last #TenTweetNephJC thread of 2022
— Nephrology Journal Club (@NephJC) December 28, 2022
Intradialytic hypotension (IDH) is deeply unpleasant but very common. We hope cooling dialysate to cause vasoconstriction prevents IDH, helping prevent myocardial stunning.
So does cooling dialysate improve cardiovascular outcomes? pic.twitter.com/mmNoIxlDxk